From SECO 2019:
[ Ссылка ]
Myco Industries launches AB Max, the newest device to treat anterior blepharitis.
The device costs about one-third as much as a leading competitor, and consumables are about half as expensive.
In addition to being more cost effective, the ABmax also has a patented pulse operational mode to improve patient comfort.
Visit this thread on ODwire.org to learn more & discuss:
[ Ссылка ]
ODwire.org: The Largest Online Community Exclusively for ECPs.
Always Free * Always Fun!
[ Ссылка ]
